Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Cancer Res. 2012 Jul 2;72(17):4383–4393. doi: 10.1158/0008-5472.CAN-11-3893

Figure 4. Amplified therapeutic determinants in gut adenocarcinomas.

Figure 4

The presence of focal amplifications (inferred copy-number > 2.3) is shown in red for recurrently amplified receptor tyrosine kinase genes across all tumor specimens (vertical bars).